AI boom, undiagnosed TB, and the cost of innovation: Britain’s quiet reckoning
From soaring chipmaker shares to preventable deaths, Britain grapples with the human and financial toll of unchecked progress—who pays, and who profits?
From soaring chipmaker shares to preventable deaths, Britain grapples with the human and financial toll of unchecked progress—who pays, and who profits?